ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial

BACKGROUND: Although aspirin is recommended for the prevention of colorectal cancer, the specific individuals for whom the benefits outweigh the risks are not clearly defined. Moreover, the precise mechanisms by which aspirin reduces the risk of cancer are unclear. We recently launched the ASPirin I...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Drew, David A., Chin, Samantha M., Gilpin, Katherine K., Parziale, Melanie, Pond, Emily, Schuck, Madeline M., Stewart, Kathleen, Flagg, Meaghan, Rawlings, Crystal A., Backman, Vadim, Carolan, Peter J., Chung, Daniel C., Colizzo, Francis P., Freedman, Matthew, Gala, Manish, Garber, John J., Huttenhower, Curtis, Kedrin, Dmitriy, Khalili, Hamed, Kwon, Douglas S., Markowitz, Sanford D., Milne, Ginger L., Nishioka, Norman S., Richter, James M., Roy, Hemant K., Staller, Kyle, Wang, Molin, Chan, Andrew T.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5286828/
https://ncbi.nlm.nih.gov/pubmed/28143522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1744-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars